Single-molecule imaging reveals the oligomeric state of functional TNFα-induced plasma membrane TNFR1 clusters in cells.


Journal

Science signaling
ISSN: 1937-9145
Titre abrégé: Sci Signal
Pays: United States
ID NLM: 101465400

Informations de publication

Date de publication:
14 01 2020
Historique:
entrez: 16 1 2020
pubmed: 16 1 2020
medline: 22 12 2020
Statut: epublish

Résumé

Ligand-induced tumor necrosis factor receptor 1 (TNFR1) activation controls nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) signaling, cell proliferation, programmed cell death, and survival and is crucially involved in inflammation, autoimmune disorders, and cancer progression. Despite the relevance of TNFR1 clustering for signaling, oligomerization of ligand-free and ligand-activated TNFR1 remains controversial. At present, models range from ligand-independent receptor predimerization to ligand-induced oligomerization. Here, we used quantitative, single-molecule superresolution microscopy to study TNFR1 assembly directly in native cellular settings and at physiological cell surface abundance. In the absence of its ligand TNFα, TNFR1 assembled into monomeric and dimeric receptor units. Upon binding of TNFα, TNFR1 clustered predominantly not only into trimers but also into higher-order oligomers. A functional mutation in the preligand assembly domain of TNFR1 resulted in only monomeric TNFR1, which exhibited impaired ligand binding. In contrast, a form of TNFR1 with a mutation in the ligand-binding CRD2 subdomain retained the monomer-to-dimer ratio of the unliganded wild-type TNFR1 but exhibited no ligand binding. These results underscore the importance of ligand-independent TNFR1 dimerization in NF-κB signaling.

Identifiants

pubmed: 31937565
pii: 13/614/eaax5647
doi: 10.1126/scisignal.aax5647
pii:
doi:

Substances chimiques

NF-kappa B 0
Receptors, Tumor Necrosis Factor, Type I 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Christos Karathanasis (C)

Institute of Physical and Theoretical Chemistry, Goethe University, Max-von-Laue-Strasse 7, 60438 Frankfurt am Main, Germany.

Juliane Medler (J)

Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Auverahaus, Grombühlstrasse 12, 97080 Würzburg, Germany.

Franziska Fricke (F)

Institute of Physical and Theoretical Chemistry, Goethe University, Max-von-Laue-Strasse 7, 60438 Frankfurt am Main, Germany.

Sonja Smith (S)

Institute for Experimental Cancer Research in Paediatrics, Goethe University, Komturstrasse 3a, 60528 Frankfurt am Main, Germany.

Sebastian Malkusch (S)

Institute of Physical and Theoretical Chemistry, Goethe University, Max-von-Laue-Strasse 7, 60438 Frankfurt am Main, Germany.

Darius Widera (D)

Stem Cell Biology and Regenerative Medicine Group, School of Pharmacy, University of Reading, RG6 6UB Reading, UK.

Simone Fulda (S)

Institute for Experimental Cancer Research in Paediatrics, Goethe University, Komturstrasse 3a, 60528 Frankfurt am Main, Germany.
German Cancer Consortium (DKTK), Heidelberg, Germany.
German Cancer Research Centre (DKFZ), Heidelberg, Germany.

Harald Wajant (H)

Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Auverahaus, Grombühlstrasse 12, 97080 Würzburg, Germany.

Sjoerd J L van Wijk (SJL)

Institute for Experimental Cancer Research in Paediatrics, Goethe University, Komturstrasse 3a, 60528 Frankfurt am Main, Germany. s.wijk@kinderkrebsstiftung-frankfurt.de ivan.dikic@biochem2.de heilemann@chemie.uni-frankfurt.de.

Ivan Dikic (I)

Institute of Biochemistry II, Goethe University Medical School, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany. s.wijk@kinderkrebsstiftung-frankfurt.de ivan.dikic@biochem2.de heilemann@chemie.uni-frankfurt.de.
Buchmann Institute for Molecular Life Sciences (BMLS), Goethe University, Max-von-Laue-Strasse 15, 60438 Frankfurt am Main, Germany.

Mike Heilemann (M)

Institute of Physical and Theoretical Chemistry, Goethe University, Max-von-Laue-Strasse 7, 60438 Frankfurt am Main, Germany. s.wijk@kinderkrebsstiftung-frankfurt.de ivan.dikic@biochem2.de heilemann@chemie.uni-frankfurt.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH